HPLC Determination of Physostigmine in the Presence of Degradation Products and Preservatives
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 14 (8) , 1061-1078
- https://doi.org/10.3109/03639048809151920
Abstract
A reversed phase, ion-pairing liquid chromatographic method was developed for the analyses of physostignine-containing pharmaceuticals in the presence of its decomposition products, eseroline and rubreserine, and preservatives methyl- and propylparaben. A satisfactory resolution for the peaks for these compounds was obtained with this isocratic method. All peaks were eluted in less than 12 minutes. The capacity factors of these compounds ranged from 1.50 to 9.27. The linearity and repeatability of this method were examined. The CV's of retention times of all compounds ranged from 0.87 to 1.81%, and the CV of physostignine peak areas was 2.17%. A gradient-elution, ion-pairing HPLC method was developed for the analyses of pharmaceutical preparations containing physostigmine, eseroline, rubreserine, and benzyl alcohol as an antibacterial agent. The capacity factors of these compounds ranged from 2.75 to 10.51. The CV of retention times ranged from 0.79 to 1.27%. This method is also suitable for the simultaneous quantitation of benzyl alcohol.This publication has 10 references indexed in Scilit:
- Determination of Physostigmine in Plasma and Brain by HPLC*,**Journal of Analytical Toxicology, 1985
- Analysis of plasma physostigmine concentrations by liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Simultaneous Determination of Hydrocortisone and Benzyl Alcohol in Pharmaceutical Formulations by Reversed-Phase High-Pressure Liquid ChromatographyJournal of Pharmaceutical Sciences, 1982
- Rapid High-Performance Liquid Chromatographic Determination of Physostigmine in PlasmaJournal of Liquid Chromatography, 1982
- Determination of pilocarpine, physostigmine, its degradation product rubreserine and preservatives by high-performance liquid chromatographyJournal of Chromatography A, 1980
- The effect of pH and sodium metabisulphite on the stability of physostigmine sulphate solutions to heat and ionizing radiationJournal of Pharmacy and Pharmacology, 1968
- A Note on the Stability of Ophthalmic Solutions Containing Pilocarpine Hydrochloride Alone and with EserineJournal of Pharmacy and Pharmacology, 1963
- A new concept of the Role of Hydrogen Ion Concentration and Buffer Systems in the Preparation of Ophthalmic Solutions*Journal of the American Pharmaceutical Association (Scientific ed.), 1947
- STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES IV. CHEMICAL STUDIES ON PHYSOSTIGMINE BREAKDOWN PRODUCTS AND RELATED EPINEPHRINE DERIVATIVESThe Journal of Pharmacology and Experimental Therapeutics, 1943
- STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES III. BREAKDOWN PRODUCTS OF PHYSOSTIGMINE; THEIR INHIBITORY EFFECT ON CHOLINESTERASE AND THEIR PHARMACOLOGICAL ACTIONThe Journal of Pharmacology and Experimental Therapeutics, 1943